Inspire Medical Net Worth
Inspire Medical Net Worth Breakdown | INSP |
Inspire Medical Net Worth Analysis
Inspire Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Inspire Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Inspire Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Inspire Medical's net worth analysis. One common approach is to calculate Inspire Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Inspire Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Inspire Medical's net worth. This approach calculates the present value of Inspire Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Inspire Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Inspire Medical's net worth. This involves comparing Inspire Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Inspire Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Inspire Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Inspire Medical's net worth research are outlined below:
Inspire Medical generated a negative expected return over the last 90 days | |
Inspire Medical has high historical volatility and very poor performance | |
The company reported the previous year's revenue of 624.8 M. Net Loss for the year was (21.15 M) with profit before overhead, payroll, taxes, and interest of 341.74 M. | |
Over 98.0% of the company shares are owned by institutional investors | |
Latest headline from simplywall.st: Inspire Medical Systems, Inc. Could Be Less Than A Year Away From Profitability |
Inspire Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Inspire Medical Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inspire Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024 Upcoming Quarterly Report | View | |
7th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
6th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Inspire Medical Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inspire target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Inspire Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
17 | Strong Buy |
Most Inspire analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Inspire stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Inspire Medical Systems, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationInspire Medical Target Price Projection
Inspire Medical's current and average target prices are 148.51 and 274.75, respectively. The current price of Inspire Medical is the price at which Inspire Medical Systems is currently trading. On the other hand, Inspire Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Inspire Medical Market Quote on 4th of June 2024
Target Price
Analyst Consensus On Inspire Medical Target Price
Know Inspire Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Inspire Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inspire Medical Systems backward and forwards among themselves. Inspire Medical's institutional investor refers to the entity that pools money to purchase Inspire Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Bank Of New York Mellon Corp | 2024-03-31 | 595.6 K | Macquarie Group Ltd | 2024-03-31 | 558.5 K | Westfield Capital Management Company, Lp | 2024-03-31 | 538.3 K | State Street Corporation | 2024-03-31 | 530.2 K | Franklin Resources Inc | 2023-12-31 | 514 K | Geode Capital Management, Llc | 2024-03-31 | 462.3 K | T. Rowe Price Associates, Inc. | 2024-03-31 | 459.8 K | Federated Hermes Inc | 2024-03-31 | 453.2 K | Ameriprise Financial Inc | 2024-03-31 | 431.4 K | Fmr Inc | 2024-03-31 | 4.4 M | Vanguard Group Inc | 2024-03-31 | 2.9 M |
Follow Inspire Medical's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.41 B.Market Cap |
|
Project Inspire Medical's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.03) | (0.03) | |
Return On Capital Employed | (0.07) | (0.07) | |
Return On Assets | (0.03) | (0.03) | |
Return On Equity | (0.04) | (0.04) |
When accessing Inspire Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Inspire Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Inspire Medical's profitability and make more informed investment decisions.
The data published in Inspire Medical's official financial statements usually reflect Inspire Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Inspire Medical Systems. For example, before you start analyzing numbers published by Inspire accountants, it's critical to develop an understanding of what Inspire Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Technology space in which it operates.
Please note, the presentation of Inspire Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inspire Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Inspire Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Inspire Medical Systems. Please utilize our Beneish M Score to check the likelihood of Inspire Medical's management manipulating its earnings.
Evaluate Inspire Medical's management efficiency
Inspire Medical Systems has return on total asset (ROA) of (0.0358) % which means that it has lost $0.0358 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0288) %, meaning that it created substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 06/04/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 06/04/2024, Liabilities And Stockholders Equity is likely to grow to about 710.7 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 19.54 | 20.52 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 19.54 | 20.52 | |
Enterprise Value Over EBITDA | (144.03) | (151.23) | |
Price Book Value Ratio | 10.41 | 9.89 | |
Enterprise Value Multiple | (144.03) | (151.23) | |
Price Fair Value | 10.41 | 9.89 | |
Enterprise Value | 5.8 B | 6.1 B |
The analysis of Inspire Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Inspire Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Inspire Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 10.5403 | Revenue 660.9 M | Quarterly Revenue Growth 0.282 | Revenue Per Share 22.454 | Return On Equity (0.03) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inspire Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inspire Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inspire Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Inspire Medical Corporate Filings
F4 | 31st of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 7th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
19th of March 2024 Other Reports | ViewVerify | |
10K | 9th of February 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
Inspire Medical Earnings Estimation Breakdown
The calculation of Inspire Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Inspire Medical is estimated to be -0.15 with the future projection ranging from a low of -0.34 to a high of -0.02. Please be aware that this consensus of annual earnings estimates for Inspire Medical Systems is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.34 Lowest | Expected EPS | -0.02 Highest |
Inspire Medical Earnings Projection Consensus
Suppose the current estimates of Inspire Medical's value are higher than the current market price of the Inspire Medical stock. In this case, investors may conclude that Inspire Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Inspire Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of June 2024 | Current EPS (TTM) | |
5 | 25.38% | -0.34 | -0.15 | -0.53 |
Inspire Medical Earnings per Share Projection vs Actual
Actual Earning per Share of Inspire Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Inspire Medical Systems predict the company's earnings will be in the future. The higher the earnings per share of Inspire Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Inspire Medical Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Inspire Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Inspire Medical should always be considered in relation to other companies to make a more educated investment decision.Inspire Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Inspire Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-05-07 | 2024-03-31 | -0.65 | -0.34 | 0.31 | 47 | ||
2024-02-06 | 2023-12-31 | -0.09 | 0.49 | 0.58 | 644 | ||
2023-11-07 | 2023-09-30 | -0.58 | -0.29 | 0.29 | 50 | ||
2023-08-01 | 2023-06-30 | -0.57 | -0.41 | 0.16 | 28 | ||
2023-05-02 | 2023-03-31 | -0.66 | -0.53 | 0.13 | 19 | ||
2023-02-07 | 2022-12-31 | -0.57 | 0.1 | 0.67 | 117 | ||
2022-11-01 | 2022-09-30 | -0.77 | -0.6 | 0.17 | 22 | ||
2022-08-02 | 2022-06-30 | -0.62 | -0.53 | 0.09 | 14 | ||
2022-05-03 | 2022-03-31 | -0.8 | -0.61 | 0.19 | 23 | ||
2022-02-08 | 2021-12-31 | -0.44 | -0.09 | 0.35 | 79 | ||
2021-11-02 | 2021-09-30 | -0.61 | -0.38 | 0.23 | 37 | ||
2021-08-03 | 2021-06-30 | -0.64 | -0.48 | 0.16 | 25 | ||
2021-05-04 | 2021-03-31 | -0.66 | -0.6 | 0.06 | 9 | ||
2021-02-23 | 2020-12-31 | -0.48 | -0.28 | 0.2 | 41 | ||
2020-11-02 | 2020-09-30 | -0.72 | -0.39 | 0.33 | 45 | ||
2020-08-04 | 2020-06-30 | -1.1 | -0.88 | 0.22 | 20 | ||
2020-05-05 | 2020-03-31 | -0.57 | -0.67 | -0.1 | 17 | ||
2020-02-25 | 2019-12-31 | -0.4 | -0.38 | 0.02 | 5 | ||
2019-11-05 | 2019-09-30 | -0.41 | -0.34 | 0.07 | 17 | ||
2019-08-06 | 2019-06-30 | -0.43 | -0.32 | 0.11 | 25 | ||
2019-05-07 | 2019-03-31 | -0.38 | -0.35 | 0.03 | 7 | ||
2019-02-26 | 2018-12-31 | -0.31 | -0.22 | 0.09 | 29 | ||
2018-11-06 | 2018-09-30 | -0.35 | -0.22 | 0.13 | 37 | ||
2018-08-07 | 2018-06-30 | -0.51 | -0.43 | 0.08 | 15 | ||
2018-06-07 | 2018-03-31 | -3.64 | -5.05 | -1.41 | 38 | ||
2018-02-28 | 2017-12-31 | 0 | -3.46 | -3.46 | 0 | ||
2017-05-04 | 2017-03-31 | 0 | -3.9 | -3.9 | 0 |
Inspire Medical Corporate Directors
Georgia GarinoisMelenikiotou | Independent Director | Profile | |
Megan CPA | Director Reporting | Profile | |
Casey Tansey | Independent Director | Profile | |
Gary Ellis | Independent Director | Profile |
Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.